Healthcare

Medibio Limited (ASX:MEB)

Industry Group : Health Care Equipment & Services | Industry Group Name : Health Care Technology

Market Price : AUD 0.0080 (0%)

(as on 2021-10-24 00:55:54)

Market Cap : AUD 14.36 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
0.008 0.009 0.008 0.008L 0.009 H 0.007L 0.016 H
Last Trade 0.008
Change% 0.0000
52 W H/L 0.016/0.007
EBITDA -1.282 M
NPAT After Abnormal Items -1.487 M
Equity 16.416 M
ROE% -9.06%
Total Liabilities 963,680
Total Revenue 1.264 M
Cash and Cash Equivalents 2.312 M

Stock Information

Share price 0.008
Market Cap 14.36 M
Price/Gross Cash Flow -15.11
Dividend Yield Excluding Special 0.00%
Ending Shares 1.795 B
52-Week Range 0.007-0.016
P/E ratio 0.000
Sector P/E --
EPS -0.10
EV/EBITDA --
Net Profit Margin (%) -1,462.38%
Gross Cash Flows Per Share -0.00
Net Gearing -13.93%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.00
Sales Per Share 0.00
Book Value Per Share 0.01

Announcements

Heading Date/Time
Proposed issue of securities - MEB  20/10/2021 4:06PM
Notice of Annual General Meeting/Proxy Form  11/10/2021 5:27PM
LUCA Launches Today  01/10/2021 12:48PM
Appointment of Dr Elizabeth Lambardo to Advisory Board  23/09/2021 8:58AM
CEO/MD Remuneration Update and Company Secretary Resignation  01/09/2021 9:45AM
Appendix 4G and Corporate Governance Statement  31/08/2021 6:17PM
Appendix 4E and Annual Report  31/08/2021 6:15PM
Medibio Quarterly Update and Cashflow Report  30/07/2021 1:48PM
Newsletter to Shareholders  07/07/2021 11:07AM
MEB Appoints R&CPMK As Communications Agency in the US  25/06/2021 8:27AM
Section 708A Cleansing Notice and Appendix 2A  18/05/2021 10:13AM
Medibio strengthens its IP protection  04/05/2021 8:41AM
Medibio Quarterly Update and Cashflow Report  30/04/2021 2:28PM
Re-submission of FDA 510(k) application  29/04/2021 8:37AM
Consumer Mental Health App Development - Second Test Phase  22/04/2021 9:10AM
Appendix 3G  15/04/2021 2:24PM
Appendix 2A  08/04/2021 3:36PM
Appendix 2A  08/04/2021 3:34PM
Appendix 2A  08/04/2021 3:31PM
Appendix 2A  08/04/2021 3:29PM
Section 708A Cleansing Notice and Appendix 2A  08/04/2021 3:24PM
Appendix 2A  08/04/2021 11:03AM
Proposed issue of Securities - MEB (Revised)  31/03/2021 1:52PM
MEB Share Purchase Plan Closes Strongly Oversubscribed  31/03/2021 12:17PM
Supplementary Prospectus  31/03/2021 12:12PM
Results of General Meeting  24/03/2021 3:07PM
Annual General Meeting - Venue  23/03/2021 3:51PM
MEB Begins Implementation of ilumen In the United Kingdom  19/03/2021 8:32AM
Medibio To Present at World Forum for Sleep Medicine  03/03/2021 8:23AM

Similar Companies

Related Articles

Load More

About Company

Founded in 1988, Medibio Limited (ASX: MEB) is involved in the operations of developing diagnostic systems for mental health illness in Australia and the United States. Mr. Brian Mower is the CFO and the interim CEO of the company. The company is currently headed in 100 Albert Road Level 4 South Melbourne, Australia.

Corporate Information

company address Level 4, 100 Albert Road, SOUTH MELBOURNE, VIC, AUSTRALIA, 3205

company phone+61 3 9692 7222

company websitehttp://www.medibio.com.au

Dividends

Ex-Dividend Date Franking DPS (AUD) Dividend Yield
30/06/2021 -- 0.000 0.00%
30/06/2020 -- 0.000 0.00%
30/06/2019 -- 0.000 0.00%
30/06/2018 -- 0.000 0.00%
30/06/2017 -- 0.000 0.00%
30/06/2016 -- 0.000 0.00%
30/06/2015 -- 0.000 0.00%
30/06/2014 -- 0.000 0.00%
30/06/2013 -- 0.000 0.00%
30/06/2012 -- 0.000 0.00%

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2022-08-30 2022
Report (Prelim) 2022-08-30 2022
Report (Interim) 2022-02-23 2022
AGM 2021-11-11 2021

Financials

Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Trading Revenue 101,656 133,500 364,628 204,878 23,100
Other Revenue 1.163 M 791,769 3.738 M 2.257 M 3.099 M
Total Revenue 1.264 M 925,269 4.102 M 2.462 M 3.122 M
Interest Income 1,330 7,562 30,077 138,501 34,241
Interest Expenses -16,282 -36,687 -13,928 -8,139 -266,659
Expenses -2.538 M -4.416 M -10.164 M -17.563 M -10.948 M
EBITDA -1.273 M -3.491 M -6.062 M -15.101 M -7.826 M
Depreciation and Amortization -198,518 -148,865 0 -1.329 M -1.727 M
Depreciation -198,518 -148,865 0 0 0
Amortisation 0 0 0 -1.329 M -1.727 M
EBIT -1.472 M -3.64 M -6.062 M -16.431 M -9.553 M
Pre Tax Profit -1.487 M -3.669 M -6.045 M -16.3 M -9.785 M
Tax Expense 0 0 0 0 0
Net Profit After Tax -1.487 M -3.669 M -6.045 M -16.3 M -9.785 M
Minority Interest 0 0 0 0 0
Preference Dividend 0 0 0 0 0
Net Abnormal Items 0 -203,549 -541,678 0 0
Reported Net Profit After Abnormal Items -1.487 M -3.872 M -6.587 M -16.3 M -9.785 M
Ending Shares 1.795 B 1.095 B 256.127 M 223.134 M 163.769 M
Weighted Average Shares 1.472 B 882.415 M 222.659 M 203.865 M 144.763 M
EPS After Abnormal Items (cents) -0.1 -0.44 -2.96 -8 -6.76
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Total Current Assets 2.664 M 861,696 1.532 M 7.886 M 7.365 M
Total Non Current Assets 14.715 M 13.152 M 11.771 M 11.178 M 11.885 M
Total Assets 17.38 M 14.014 M 13.303 M 19.064 M 19.25 M
Total Current Liabilities 963,680 1.404 M 4.699 M 5.078 M 5.936 M
Total Non Current Liabilities 0 0 0 0 0
Total Liabilities 963,680 1.404 M 4.699 M 5.078 M 5.936 M
Net Assets 16.416 M 12.609 M 8.604 M 13.986 M 13.314 M
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Net Operating Cash -1.701 M -3.589 M -6.83 M -12.268 M -5.425 M
Net Invested Cash -1.832 M -1.505 M -1.085 M -399,615 34,241
Net Financing Cash Flows 4.922 M 4.554 M 3.125 M 13.781 M 9.361 M
Beginning Cash 812,503 1.333 M 6.123 M 5.01 M 1.04 M
End Cash Position 2.312 M 812,503 1.333 M 6.123 M 5.01 M
Exchange Rate Adjustments 109,742 19,157 0 0 0
Other Cash Adjustments 0 0 0 0 0
Ending Cash 2.312 M 812,503 1.333 M 6.123 M 5.01 M

© Morningstar, Inc. 2021. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the market indices, commodities and regulatory news headlines, and other data or content contained herein to be accurate, complete, or timely, and nor shall they have any liability for its use or distribution. The data contained herein: (1) is proprietary to Morningstar and/or its affiliates (collectively, “Morningstar”) and/or their content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Our publications, ratings and products should be viewed as an additional investment resource, and not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your financial situation, contact a professional financial adviser. Some material is copyrighted and published under licence from ASX Operations Pty. Ltd. ACN 004523782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK